{"canonical":"https://abierto.us/vendors/gencyte-therapeutics-inc-klltvaecbmn8","key":"KLLTVAECBMN8","name":"GENCYTE THERAPEUTICS INC","uei":"KLLTVAECBMN8","city":"SAN CARLOS","state":"CA","awards":2,"obligated":"499990.00","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"7ZVP4","parent_name":"GENCYTE THERAPEUTICS INC","also_known_as":[],"country":"USA","actions":5,"first_action":"2024-02-26","last_action":"2026-07-16","breakdowns":{"naics":[{"key":"541715","name":null,"awards":2,"obligated":"499990.00"}],"places":[{"key":"CA","name":null,"awards":2,"obligated":"499990.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":2,"obligated":"499990.00"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"499990.00"},{"key":"SMALL BUSINESS SET ASIDE - PARTIAL","name":null,"awards":1,"obligated":"0.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"499990.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":2,"obligated":"499990.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":2,"obligated":"499990.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N91025C00046_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91025C00046_7529_-NONE-_-NONE-/","piid":"75N91025C00046","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"KLLTVAECBMN8","recipient_name":"GENCYTE THERAPEUTICS INC","recipient_uei":"KLLTVAECBMN8","recipient_cage":"7ZVP4","recipient_city":"SAN CARLOS","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2025-09-03","last_action_date":"2026-07-16","actions":3,"obligated":"499990.00","current_total_value":"499990.00","potential_total_value":"499990.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":16,"description":"PHASE I SBIR CONCEPT AWARD FOR LOGIC GATED MOLECULAR ADAPTOR SYSTEM FOR JMML TREATMENT","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N91023C00014_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91023C00014_7529_-NONE-_-NONE-/","piid":"75N91023C00014","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"KLLTVAECBMN8","recipient_name":"GENCYTE THERAPEUTICS INC","recipient_uei":"KLLTVAECBMN8","recipient_cage":"7ZVP4","recipient_city":"SAN JOSE","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-02-26","last_action_date":"2024-06-11","actions":2,"obligated":"0","current_total_value":"354964.00","potential_total_value":"354964.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - PARTIAL","offers_received":17,"description":"THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM FEBRUARY 26, 2024 TO AUGUST 26, 2024","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}